Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics

Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics

Abstract Background The well-established benefit of Low-Dense-Lipoprotein-cholesterol (LDL-c) lowering treatments (LLTs) has led clinical guidelines to lower the cardiovascular prevention targets. Despite this, there is a surprising scarcity of real-world studies (RWS) evaluating whether recommendat...

Full description

Bibliographic Details
Main Authors: Mario Luca Morieri, Angelo Avogaro, Gian Paolo Fadini, the DARWIN-T2D Network of the Italian Diabetes Society
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Cardiovascular Diabetology
Subjects:
Cardiovascular prevention
Diabetes
LDL cholesterol targets
Risk reduction
Numbers needed to treat
PCSK9 inhibitors
Online Access:http://link.springer.com/article/10.1186/s12933-020-01164-8

Internet

http://link.springer.com/article/10.1186/s12933-020-01164-8

Similar Items